🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Mariko Asaoka

Tokyo Medical University

ORCID: 0000-0002-4573-4572

Also affiliated with Tokyo Medical University Hospital

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 13 papers. Top paper: “M1 Macrophage and M1/M2 ratio defined by transcriptomic signatures resemble only part of their conventional clinical characteristics in breast cancer”.

M1 Macrophage and M1/M2 ratio defined by transcriptomic signatures resemble only part of their conventional clinical characteristics in breast cancer

Scientific Reports(2020)10.1038/s41598-020-73624-w

N/A

0DataRank · unranked

216 citations

Yoshihisa Tokumaru, Mariko Asaoka, Li Yan, Vikas Satyananda, Ryusei Matsuyama +7 more

CD8 T Cell Score as a Prognostic Biomarker for Triple Negative Breast Cancer

International Journal of Molecular Sciences(2020)10.3390/ijms21186968

N/A

0DataRank · unranked

217 citations

Mariko Asaoka, Yoshihisa Tokumaru, Li Yan, Ryusei Matsuyama, Takashi Ishikawa +3 more

Abundance of Regulatory T Cell (Treg) as a Predictive Biomarker for Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer

Cancers(2020)10.3390/cancers12103038

N/A

0DataRank · unranked

106 citations

Mariko Asaoka, Yoshihisa Tokumaru, Fernando A. Angarita, Li Yan, Ryusei Matsuyama +5 more

Biologically Aggressive Phenotype and Anti-cancer Immunity Counterbalance in Breast Cancer with High Mutation Rate

Scientific Reports(2020)10.1038/s41598-020-58995-4

N/A

0DataRank · unranked

87 citations

Mariko Asaoka, Li Yan, Omar M. Rashid, Masanori Oshi, Takashi Ishikawa +3 more

Molecular Biological Features of Nottingham Histological Grade 3 Breast Cancers

Annals of Surgical Oncology(2020)10.1245/s10434-020-08608-1

N/A

0DataRank · unranked

54 citations

Masanori Oshi, Mariko Asaoka, Li Yan, Itaru Endo, Kazuaki Takabe +1 more

Prevalence and clinical relevance of tumor-associated tissue eosinophilia (TATE) in breast cancer

Surgery(2020)10.1016/j.surg.2020.07.052

N/A

0DataRank · unranked

24 citations

Yoshihisa Tokumaru, Mariko Asaoka, Masanori Oshi, Kristopher Attwood, Kazuhiro Yoshida +3 more

Should we target “intermediate expression” of HER2 in older estrogen receptor positive patients?

Translational Cancer Research(2020)10.21037/tcr-20-2231

N/A

0DataRank · unranked

2 citations

Lan Le, Mariko Asaoka, Manabu Futamura, Takashi Ishikawa, Kazuhiro Yoshida +2 more

Immunogenicity and transcriptomic biology in Nottingham histologic grade 3 breast cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e12563

N/A

0DataRank · unranked

0 citations

Masanori Oshi, Mariko Asaoka, Li Yan, Kazuaki Takabe, Hideo Takahashi

NR2F1, a Tumor Dormancy Marker, Is Expressed Predominantly in Cancer-Associated Fibroblasts and Is Associated with Suppressed Breast Cancer Cell Proliferation

Cancers(2022)10.3390/cancers14122962

N/A

0DataRank · unranked

39 citations

Arya Mariam Roy, Yoshihisa Tokumaru, Shipra Gandhi, Mariko Asaoka, Masanori Oshi +4 more

Association of NR2F1, a tumor dormancy marker, with cancer cell proliferation and lymph node metastasis, and expression in cancer-associated fibroblasts in breast cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e12550

N/A

0DataRank · unranked

3 citations

Masanori Oshi, Mariko Asaoka, Yoshihisa Tokumaru, Takashi Ishikawa, Kazuaki Takabe +1 more

Establishment of a novel BRCAness score that predicts response to PARP inhibitors.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.549

N/A

0DataRank · unranked

0 citations

Shipra Gandhi, Rongrong Wu, Mariko Asaoka, Li Yan, Akimitsu Yamada +6 more

Intratumoral Tumor Infiltrating Lymphocytes (TILs) are Associated With Cell Proliferation and Better Survival But Not Always With Chemotherapy Response in Breast Cancer

Annals of Surgery(2023)10.1097/sla.0000000000005954

N/A

0DataRank · unranked

40 citations

Masanori Oshi, Mariko Asaoka, Yan Li, Matthew G.K. Benesch, Thaer Khoury +6 more

The American Joint Committee on Cancer (AJCC) Breast Cancer Staging, Eighth Edition, is more Reflective of Cancer Biology than the Seventh Edition

Annals of Surgical Oncology(2025)10.1245/s10434-025-16889-7

N/A

0DataRank · unranked

5 citations

Mariko Asaoka, Farhad Ghasemi, Kohei Chida, Arya Mariam Roy, Yan Li +3 more